đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will evaluate the immunogenicity of a reduced dosing schedule of...
Status
Completed
Location
Chris Hani Baragwanath Academic Hospital
Start Date
2017-01-09
Trial ID
NCT02943902
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
Pneumococcus is a group of bacteria that can cause pneumonia, meningitis an...
Status
Completed
Location
Pasteur Institute of Ho Chi Minh City
Start Date
2013-09-30
Trial ID
NCT01953510
The study aims to evaluate the safety and immunogenicity of the 10-valent a...
Status
Unknown
Location
Papua New Guinea Institute of Medical Research
Start Date
2011-11
Trial ID
NCT01619462
Treatments Being Tested
The purpose of this phase III study is to demonstrate immunologic non-infer...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-28
Trial ID
NCT05721456
Treatments Being Tested
Before the introduction of pneumonia vaccines in 2000, between 700,000 - 1 ...
Status
Completed
Location
KEMRI Wellcome Trust Research Programme
Start Date
2019-03-21
Trial ID
NCT03489018
The purpose of this study is to determine whether an early schedule of a co...
Status
Completed
Location
Menzies School of Health Research
Start Date
2011-08
Trial ID
NCT01174849
Treatments Being Tested
The National Vaccine Evaluation Consortium conducts Department of Health fu...
Status
Withdrawn
Location
Hertfordshire primary care
Start Date
TBD
Trial ID
NCT02918708
Treatments Being Tested
This study will assess the safety, reactogenicity and immunogenicity of two...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-27
Trial ID
NCT01204658
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-18
Trial ID
NCT01746108
Treatments Being Tested